Imagia’s mission is to detect and quantify cancer changes early. Despite systematic imaging and new genetic testing, tumor changes are often detected too late to improve cancer patient outcomes. Our Artificial Clinical Intelligence Platform enables us to provide critical information and timely imaging insights for primary tumors and metastasis for each cancer patient thus personalizing their cancer care continuum. Deep Radiomics™ — uniting radiomics and deep learning — utilizes existing routine clinical imaging data to discover robust imaging biomarkers that predict cancer patient outcomes.